The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
Recruiting · NCT05218850 · Interventional (participants receive a specific treatment) · Lead sponsor: Children's Hospital Los Angeles
View the official record on ClinicalTrials.gov →Interventions studied
Butyrate
What this trial is about
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.
Who can take part
Age range
7 Years to 21 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- 7-21 years, mild to moderate ulcerative colitis
Exclusion criteria
- UC therapy within 4 weeks of study medication initiation
- infectious colitis, -pregnancy
Where it is running
1 location listed across 1 US state.
- Children's Hospital Los Angeles - Los Angeles, California, United States